Search

Your search keyword '"Yamao, Kenji"' showing total 962 results

Search Constraints

Start Over You searched for: Author "Yamao, Kenji" Remove constraint Author: "Yamao, Kenji"
962 results on '"Yamao, Kenji"'

Search Results

4. Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis

5. Supplementary Table 3 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

6. Supplementary Fig. 2 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

7. Supplementary Fig. 1 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

8. Supplementary Table 4 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

9. Supplementary Figure legends from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

10. Supplementary Table 1 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

11. Data from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

12. Supplementary Table 2 from Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer

13. Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study

14. Prediction of the Probability of Malignancy in Mucinous Cystic Neoplasm of the Pancreas With Ovarian-Type Stroma: A Nationwide Multicenter Study in Japan

16. Supplementary Figure 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

17. Supplementary Figure 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

18. Supplementary Figure Legend from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

19. Supplementary Table 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

20. Supplementary Table 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

33. ENDOSCOPIC ULTRASOUND CAN DIFFERENTIATE HIGH-GRADE PANCREATIC INTRAEPITHELIAL NEOPLASIA, SMALL PANCREATIC DUCTAL ADENOCARCINOMA, AND BENIGN STENOSIS. A MULTICENTER COMPARATIVE STUDY.

37. Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?

50. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition

Catalog

Books, media, physical & digital resources